Nyxoah (NYXH) News Today → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free NYXH Stock Alerts $10.10 -0.33 (-3.16%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 20 at 1:38 AM | americanbankingnews.comQ2 2024 EPS Estimates for Nyxoah S.A. (NASDAQ:NYXH) Decreased by HC WainwrightMay 19 at 6:02 AM | americanbankingnews.comOppenheimer Cuts Nyxoah (NASDAQ:NYXH) Price Target to $15.00May 19 at 5:30 AM | americanbankingnews.comHC Wainwright Reaffirms "Buy" Rating for Nyxoah (NASDAQ:NYXH)May 18 at 4:44 AM | americanbankingnews.comFY2024 EPS Estimates for Nyxoah S.A. (NASDAQ:NYXH) Increased by Cantor FitzgeraldMay 17 at 10:51 PM | uk.investing.comNyxoah stock price target cut, maintains Overweight on Q1 revenue reportMay 17 at 6:06 AM | americanbankingnews.comCantor Fitzgerald Lowers Nyxoah (NASDAQ:NYXH) Price Target to $17.00May 17 at 4:40 AM | americanbankingnews.comStifel Nicolaus Reiterates Buy Rating for Nyxoah (NASDAQ:NYXH)May 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Nyxoah Amidst Soaring Genio System Sales and Strategic PartnershipsMay 15, 2024 | markets.businessinsider.comCantor Fitzgerald Reaffirms Their Buy Rating on Nyxoah (NYXH)May 14, 2024 | investorplace.comNYXH Stock Earnings: Nyxoah Misses EPS, Beats Revenue for Q1 2024May 14, 2024 | finance.yahoo.comNyxoah Reports First Quarter 2024 Financial and Operating ResultsMay 13, 2024 | globenewswire.comNyxoah to Release First Quarter 2024 Financial Results on May 14, 2024May 10, 2024 | finance.yahoo.comInvitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024May 10, 2024 | globenewswire.comInvitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 12, 2024April 11, 2024 | markets.businessinsider.comNyxoah Appoints Maurits Boon As Chief Medical OfficerApril 11, 2024 | globenewswire.comNyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical OfficerApril 11, 2024 | benzinga.comWhy Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving PremarketMarch 29, 2024 | finance.yahoo.comInformation on the total number of voting rights and sharesMarch 26, 2024 | markets.businessinsider.comBuy Rating Affirmed for Nyxoah’s Genio System Amid Strategic Partnerships and Market Capture PotentialMarch 25, 2024 | globenewswire.comNyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery FoundationMarch 20, 2024 | markets.businessinsider.comBuy Rating Affirmed for Nyxoah Amid Promising DREAM Study Results and Market Growth ProjectionsMarch 19, 2024 | msn.comNyxoah says Genio pivotal study meets primary endpointsMarch 19, 2024 | globenewswire.comNyxoah Announces DREAM U.S. Pivotal Study Meets Primary EndpointsMarch 7, 2024 | seekingalpha.comNyxoah S.A. (NYXH) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | finance.yahoo.comNyxoah S.A. (NASDAQ:NYXH) Q4 2023 Earnings Call TranscriptMarch 6, 2024 | markets.businessinsider.comBuy Rating Affirmed for Nyxoah Amid Record Genio Sales and Strong Growth ProspectsMarch 5, 2024 | investorplace.comNYXH Stock Earnings: Nyxoah Misses EPS, Beats Revenue for Q4 2023March 5, 2024 | globenewswire.comNyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating ResultsMarch 5, 2024 | marketbeat.comStifel Nicolaus Increases Nyxoah (NASDAQ:NYXH) Price Target to $20.00Stifel Nicolaus raised their target price on shares of Nyxoah from $10.00 to $20.00 and gave the stock a "buy" rating in a report on Tuesday.March 4, 2024 | benzinga.comPreview: Nyxoah's EarningsFebruary 29, 2024 | globenewswire.comNyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceFebruary 26, 2024 | msn.comButterfly Network, ThermoGenesis among healthcare moversFebruary 15, 2024 | finance.yahoo.comNyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024February 15, 2024 | globenewswire.comNyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024February 9, 2024 | morningstar.comNyxoah SA Ordinary Shares NYXHJanuary 17, 2024 | finance.yahoo.comNyxoah Announces 2024 Strategic PrioritiesJanuary 10, 2024 | msn.comNyxoah expects to almost double revenue in 4Q23January 9, 2024 | finance.yahoo.comNyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2023December 12, 2023 | markets.businessinsider.comBuy Rating on Nyxoah’s Genio System Amid Strong Market Potential and Positive Clinical DataDecember 11, 2023 | finance.yahoo.comNyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®November 21, 2023 | finance.yahoo.comNyxoah to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNovember 12, 2023 | finance.yahoo.comNyxoah S.A. (NASDAQ:NYXH) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | markets.businessinsider.comBuy Rating for Nyxoah: Anticipated FDA Approval, Market Expansion, and Financial StabilityNovember 8, 2023 | finance.yahoo.comNyxoah Reports Third Quarter 2023 Financial and Operating ResultsOctober 26, 2023 | finance.yahoo.comNyxoah to Release Third Quarter 2023 Financial Results on November 8, 2023October 1, 2023 | markets.businessinsider.comKepler Capital Keeps Their Buy Rating on Nyxoah (NYXH)September 29, 2023 | markets.businessinsider.comBuy Rating on Nyxoah Amid Potential Market Expansion through ResMed Partnership and Genio Sales ProspectSeptember 12, 2023 | finance.yahoo.comNyxoah to Participate in the Cantor Fitzgerald Global Healthcare ConferenceSeptember 5, 2023 | finance.yahoo.comNyxoah to Participate in Upcoming Investor ConferencesAugust 11, 2023 | markets.businessinsider.comKepler Capital Sticks to Their Buy Rating for Nyxoah (NYXH) Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… NYXH Media Mentions By Week NYXH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NYXH News Sentiment▼0.160.42▲Average Medical News Sentiment NYXH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NYXH Articles This Week▼201▲NYXH Articles Average Week Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aclarion News Today Alpha Tau Medical News Today Alvotech News Today American Oncology Network News Today Artelo Biosciences News Today bioAffinity Technologies News Today BriaCell Therapeutics News Today Bullfrog AI News Today CareCloud News Today CareCloud News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NYXH) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyShocking: One AI startup's revenue could surge 4,735%Manward PressUrgent Nvidia WarningAltimetry"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA once-in-a-century investment opportunityStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
